rs863225094
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP2PP3PP5_Very_Strong
The NM_014225.6(PPP2R1A):c.773G>A(p.Arg258His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_014225.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP2R1A | NM_014225.6 | c.773G>A | p.Arg258His | missense_variant | Exon 6 of 15 | ENST00000322088.11 | NP_055040.2 | |
PPP2R1A | NM_001363656.2 | c.236G>A | p.Arg79His | missense_variant | Exon 6 of 15 | NP_001350585.1 | ||
PPP2R1A | NR_033500.2 | n.717G>A | non_coding_transcript_exon_variant | Exon 5 of 14 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1445402Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 718976
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Houge-Janssens syndrome 2 Pathogenic:4
[ACMG/AMP: PS2, PS3_Moderate, PM2, PP3] This alteration is de novo in origin as it was not detected in the submitted parental specimens (identity confirmed) [PS2], is supported by well-established in vitro or in vivo functional studies to have a damaging effect on protein function or splicing [PS3_Moderate], is absent from or rarely observed in large-scale population databases [PM2], is predicted to be damaging by multiple functional prediction tools [PP3]. -
- -
Same nucleotide change resulting in same amino acid change has been previously reported as de novoo and observed in at least four similarly affected unrelated individuals (ClinVar ID: VCV000217458.5, PMID: 26168268, 33106617, and 30755392, PS2 and PS4). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:3
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 258 of the PPP2R1A protein (p.Arg258His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability syndrome (PMID: 26168268, 30755392, 32901917, 33106617). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 217458). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PPP2R1A protein function. Experimental studies have shown that this missense change affects PPP2R1A function (PMID: 26168268). For these reasons, this variant has been classified as Pathogenic. -
Published functional studies showed R258H causes impaired binding between the A and B subunits of PP2A and decreases PP2A phosphatase activity (Houge et al., 2015; Lenaerts et al., 2020); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26197069, 26168268, 27485451, 27294619, 33106617, 32901917, 30755392) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at